ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

SXTP 60 Degrees Pharmaceuticals Inc

0.2824
0.0021 (0.75%)
2024年6月26日 - 終了
15分遅延
名称 銘柄コード 市場 種別
60 Degrees Pharmaceuticals Inc SXTP NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0021 0.75% 0.2824 07:17:00
始値 安値 高値 終値 前日終値
0.2783 0.2501 0.2812 0.2649 0.2803
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1120:59GLOBE60 Degrees Pharmaceuticals Receives FDA Orphan Drug..
2024/5/3020:59GLOBEEnrollment in 60 Degrees Pharmaceuticals Clinical Trial of..
2024/5/2020:59GLOBE60 Degrees Pharmaceuticals Funds Babesia spp Testing in..
2024/5/1602:45GLOBE60 Degrees Pharmaceuticals Announces First Quarter 2024..
2024/5/0820:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
2024/5/0220:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
2024/4/0320:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
2024/3/1420:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
2024/2/2106:00EDGAR2Form 8-K - Current report
2024/2/2021:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
2024/2/0821:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
2024/2/0305:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0102:00PRNUSWallachBeth Capital Announce Closing of 60 Degrees..
2024/2/0101:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
2024/1/3023:45PRNUSWallachBeth Capital Announces Pricing of 60 Degrees..
2024/1/3023:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
2024/1/3014:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/2307:01EDGAR2Form 8-K - Current report
2024/1/2221:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
2024/1/1704:56EDGAR2Form 8-K - Current report
2024/1/1621:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
2023/12/2621:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
2023/11/1521:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
2023/10/1921:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
2023/10/1305:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
2023/9/1905:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
2023/9/0620:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
2023/8/3020:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
2023/8/2220:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
2023/8/1520:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
2023/7/3120:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
2023/7/1502:30PRNUSWallachBeth Capital Announce Closing Of 60 Degrees..
2023/7/1501:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
2023/7/1302:45PRNUSWallachBeth Capital Announce Pricing Of 60 Degrees..
2023/7/1301:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..

最近閲覧した銘柄

Delayed Upgrade Clock